FAMOUS NY ORTHOPEDIC CENTER TO PARTNER WITH GOOD SAM PARENT TENET

Got back problems? Good Samaritan hospital has your back. The hospital’s parent company, Tenet Healthcare, is bringing the world-renowned Hospital for Special Surgery to West Palm Beach. In the latest out-of-area medical facility partnership with local providers, Good Sam’s parent has teamed with the Hospital for Special Surgery to open an orthopedic care center at 300 Palm Beach Lakes Blvd., across from Good Sam. HSS has been rated the No. 1 hospital for orthopedics for eight consecutive years, according to U.S. News & World Report. Through a Tenet subsidiary, United Surgical Partners International, plans are to offer outpatient orthopedic care including diagnostic services, ambulatory surgery, rehabilitation and sports programs. The facility will be staffed by HSS doctors, some of whom will still work at the main campus in New York.

MORE “FAMOUS NY ORTHOPEDIC CENTER TO PARTNER WITH GOOD SAM PARENT TENET”

HSS, TENET AND USPI ANNOUNCE AGREEMENT TO OPEN ORTHOPEDIC CARE FACILITY IN WEST PALM BEACH

Hospital for Special Surgery (HSS), Tenet Healthcare Corporation (“Tenet”) (NYSE:THC) and United Surgical Partners International (USPI), a Tenet subsidiary, today announced that they have entered into a definitive agreement for a joint partnership to create an orthopedic care center in West Palm Beach, Florida.

MORE “HSS, TENET AND USPI ANNOUNCE AGREEMENT TO OPEN ORTHOPEDIC CARE FACILITY IN WEST PALM BEACH”

SCRIPPS JUPITER RESEARCH SPIN OFF, EXPANSION THERAPEUTICS, RAISES $55.3 MILLION IN SERIES A FINANCING TO ADVANCE PORTFOLIO OF NOVEL RNA TARGETED SMALL MOLECULE MEDICINES TO TREAT RARE DISEASES

Expansion Therapeutics, Inc., a new 5AM Ventures formed private company focused on the discovery and development of ribonucleic acid (RNA) targeted small molecule medicines, announced today the close of a $55.3 million Series A financing co-led by 5AM Ventures, Kleiner Perkins, Novartis Venture Fund, and Sanofi Ventures with participation from RA Capital Management and Alexandria Venture Investments. Proceeds will advance Expansion’s portfolio of small molecule drugs targeting key human disease-driving RNAs with an initial focus on expansion repeat disorders, a set of approximately 30 genetic diseases that currently have no satisfactory treatments.   Expansion Therapeutics’ operations will be divided between Jupiter and San Diego. The company is expected to have eight employees in Jupiter.

MORE “SCRIPPS JUPITER RESEARCH SPIN OFF, EXPANSION THERAPEUTICS, RAISES $55.3 MILLION IN SERIES A FINANCING TO ADVANCE PORTFOLIO OF NOVEL RNA TARGETED SMALL MOLECULE MEDICINES TO TREAT RARE DISEASES”